Beyond the Rash: The Devastating Course of Meningococcal Purpura Fulminans in an Unvaccinated Young Adult
- PMID: 40786404
- PMCID: PMC12334115
- DOI: 10.7759/cureus.87617
Beyond the Rash: The Devastating Course of Meningococcal Purpura Fulminans in an Unvaccinated Young Adult
Abstract
Purpura fulminans (PF) is a life-threatening thrombotic disorder characterized by rapidly progressive cutaneous hemorrhagic necrosis, disseminated intravascular coagulation (DIC), and multi-organ failure. Most commonly associated with meningococcemia, PF requires early recognition for optimal outcomes. This report presents the case of a 26-year-old immunocompetent but unvaccinated male who developed PF secondary to meningococcemia, complicated by refractory septic shock, multi-organ failure, and extensive tissue necrosis. His clinical course underscores the aggressive nature of this condition, the critical need for early recognition, and the importance of primary prevention through meningococcal vaccination. The patient's unvaccinated status highlights persistent gaps in vaccination uptake, particularly among individuals outside of university settings. Co-infection with COVID-19 and underlying alcohol use disorder may have contributed to immune dysregulation and increased disease severity. This case also raises awareness of the potential role of COVID-19 in the pathogenesis of meningococcemia. PF remains a dermatologic and hematologic emergency with high mortality, necessitating rapid diagnosis and a multidisciplinary treatment approach. Strengthening vaccination education and advocacy is essential to reduce the burden of PF and its complications.
Keywords: acute infectious purpura fulminans; alcohol use disorder (aud); covid and purpura fulminans; medical dermatology; meningococcemia; neisseria meningitidis; vaccine preventable diseases.
Copyright © 2025, Malinosky et al.
Conflict of interest statement
Human subjects: Informed consent for treatment and open access publication was obtained or waived by all participants in this study. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.
Figures
References
-
- Understanding purpura fulminans in adult patients. Contou D, Urbina T, de Prost N. Intensive Care Med. 2022;48:106–110. - PubMed
-
- Perera TB, Murphy-Lavoie HM. StatPearls. Treasure Island, FL: StatPearls Publishing; 2023. Purpura fulminans. - PubMed
-
- Purpura fulminans: recognition, diagnosis and management. Chalmers E, Cooper P, Forman K, et al. Arch Dis Child. 2011;96:1066–1071. - PubMed
-
- Purpura fulminans: Mechanism and management of dysregulated hemostasis. Colling ME, Bendapudi PK. Transfus Med Rev. 2018;32:69–76. - PubMed
-
- Meningococcal vaccination of adolescents in the United States: past successes and future considerations. Presa J, Findlow J, Zimet GD. J Adolesc Health. 2024;74:1068–1077. - PubMed
Publication types
LinkOut - more resources
Full Text Sources